CHISINAU, Moldova, May 16, 2024 /PRNewswire/ — Moldova is positioning itself as a rising tech hub with the release of the “IT Investment Guide for Moldova“, prepared by Emerging Europe. This guide provides detailed insights into Moldova’s dynamic IT sector, showcasing strategic advantages, opportunities, and incentives for investors.

The Moldova Innovation Technology Park (MITP) is central to this transformation, driving the nation’s digital agenda and fostering a robust innovation ecosystem. Hosting over 21,190 IT specialists, MITP significantly contributes to Moldova’s GDP and IT exports.

Key Advantages of MITP:

• Single Tax Rate: MITP residents enjoy a single tax rate of 7%, replacing the entire tax burden for companies and employees.
• Zero Corporate Income Tax: Resident companies are exempt from corporate income tax, local taxes, real estate, and road taxes.
• Work Permits: The IT Visa Programme offers four-year work permits for top managers and two-year permits for IT specialists and their families.
• Talent and Education: Moldova has a strong pool of IT graduates, supported by leading universities and training programs.

Growth and Achievements:

Moldova’s IT sector has shown remarkable growth and resilience. Between 2016 and 2022, the sector achieved a 37.1% annual revenue growth rate and a 40% annual growth in IT exports. The IT sector now constitutes a significant part of Moldova’s economy, with MITP accounting for about 80% of the sector and five percent of the nation’s exports.

The guide highlights success stories of international and local companies thriving in Moldova’s business environment, including Amdaris, Endava, Bloomcoding, and Crunchyroll. These companies have leveraged MITP’s benefits to expand and innovate in their respective fields.

Strategic Positioning:

Moldova’s alignment with the European Union’s Digital Transformation Strategy enhances its appeal to investors. The country’s commitment to digitalization is evident in its advanced public services and robust infrastructure. Moldova ranks highly in the IT Competitiveness Index, surpassing many regional peers in talent availability, business environment, and economic impact.

A Promising Future:

Moldova’s digital transformation strategy aims for 100% digitalization of public services, setting a high standard for tech-driven economic development. For investors and businesses exploring opportunities in Eastern Europe, Moldova offers a compelling proposition. The “IT Investment Guide for Moldova” showcases the country’s achievements and serves as a roadmap to its digital future.

Photo – https://mma.prnewswire.com/media/2414983/MITP_Investment_Guide.jpg

View original content:https://www.prnewswire.co.uk/news-releases/moldova-innovation-technology-park-unveils-comprehensive-it-investment-guide-highlighting-tech-potential-302148108.html

Accion Venture Lab, the Mastercard Center for Inclusive Growth, and the Dutch entrepreneurial development bank FMO, today announce the Fintech for Inclusion Global Summit that will take place in London on Thursday, September 12.

The summit will see over 40 fintech companies from 5 continents come together with investors, regulators, and other stakeholders in the global inclusive fintech community to discuss how innovations in embedded finance, AI, and other emerging technologies can be leveraged to meet the financial needs of vulnerable communities, including women and smallholder farmers. Globally, nearly 2 billion people are excluded from the financial system, lacking a safe place to save money, credit to manage and grow businesses, and insurance to protect against disasters. Micro, small and medium businesses are facing a $5 trillion credit gap.

Accion Venture Lab’s Managing Partner Rahil Rangwala said, “By bringing this group of fintech innovators together in London – one of the world’s most dynamic financial capitals – we can explore new ways of providing high-quality financial solutions to underserved clients globally. Participants will learn the latest industry insights and forge new partnerships, as they adapt to the rapidly evolving business landscape.”

Companies present at the summit are already leveraging new uses of technology and data to provide responsible financial services to low-income groups in innovative new ways. From using transport data to provide financing to operator-owned truck drivers in Pakistan, to deploying AI so small-scale pharmacies in Kenya can improve access to quality medicines and reduce waste, they are solving pain points for small businesses and low-income groups across emerging economies.

Mastercard Center for Inclusive Growth’s Executive Vice President for Global Programs, Payal Dalal, comments that: “With their ability to connect underserved people to the digital economy, often for the first time, fintech innovators have a key role to play in tackling global challenges and making economic growth more inclusive. The Fintech for Inclusion Summit will bring together leaders and frontline practitioners to share their learnings and build new connections, which is a vital part of driving scale.”

Speaking on the topic, Marieke Roestenberg, Manager of FMO Ventures Program, said: “We are pleased to once more co-host this important event with Accion Venture Lab – now in partnership with the Mastercard Center for Inclusive Growth – to bring together industry leaders focused on developing innovative fintech solutions for underserved communities. Holding the event in London this year will enable more key stakeholders to join the conversation and explore collaboration opportunities.”

Accion Venture Lab organizes the Fintech for Inclusion Global Summit as part of its work with entrepreneurs to build scalable businesses that address gaps in financial services around the world. It is a leading early stage fintech investor with a 10+ year track record of delivering financial and social returns. With its global team, it provides hands on strategic and operational support that is critical to the success of early-stage companies, while quickly spotting and responding to global trends, and sharing learnings across geographies.

Speakers will include TS Anil, CEO of Monzo, Jorn Lambert, Chief Product Officer of Mastercard, Jonathan Whittle, Managing Partner of Quona, and Michael Schlein, CEO of Accion. Conference partners include the Mastercard Center for Inclusive Growth, Citi Foundation, and FMO Entrepreneurial Bank. For more information and tickets see www.fintechforinclusionsummit.com

The post Fintech for Inclusion Global Summit to bring some of world’s most innovative financial start-ups to London on September 12 appeared first on HIPTHER Alerts.

VANCOUVER, BC, May 16, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) announces that the Ontario Securities Commission (the “OSC“) has issued a failure to file cease trade order (“FFCTO“) under National Policy 11-207 Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions (“NP 11-207“), prohibiting the trading by any person of any securities of the Company in Canada, including trades in the Company’s common shares made through the Canadian Securities Exchange.

The FFCTO was issued as a result of the delay in filing the Company’s audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“) and interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024, and the Required Interim Filings were required to be made no later than April 1, 2024.

The OSC had previously granted, on February 29, 2024, a management cease trade order, which has been been revoked and replaced by the FFCTO dated May 15, 2024.

The Company is working diligently to facilitate the completion of the Required Annual Filings and the Required Interim Filings and expects to be in a position to file in the very near future. The Company anticipates that the FFCTO will remain in place until such time as the Required Annual Filings and Required Interim Filings are filed and the OSC subsequently revokes the FFCTO.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and its HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Cautionary Statements Regarding Forward Looking Information

This news release contains certain “forward-looking information” and “forward-looking statements” (collectively “forward-looking statements”) within the meaning of applicable securities legislation. Forward-looking statements are frequently, but not always, identified by words such as “expects”, “anticipates”, “believes”, “intends”, “estimates”, “potential”, “possible”, and similar expressions, or statements that events, conditions, or results “will”, “may”, “could”, or” should” occur or be achieved. All statements, other than statements of historical fact, included herein, without limitation, statements relating to the Required Annual Filings and the Required Interim Fillings, including the ability of the Company to file the Required Annual Filings and the Required Interim Fillings by the timeline set out in this news release and any revocation of the FFCTO are forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements reflect the beliefs, opinions and projections on the date the statements are made and are based upon a number of assumptions and estimates that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Many factors, both known and unknown, could cause actual results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements and the parties have made assumptions and estimates based on or related to many of these factors. Such factors include, without limitation, the ability of the Company to complete its audit and file the Required Annual Filings and, subsequently, its Required Interim Filings as currently anticipated, the Company’s ability to advance its business plans and the results thereof, continued availability of capital, and changes in general economic, market and business conditions. Readers should not place undue reliance on the forward-looking statements and information contained in this news release concerning these items. The Company does not assume any obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by applicable securities laws.

Logo: https://mma.prnewswire.com/media/2415135/BioVaxys_Technology_Corp_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-announces-failure-to-file-cease-trade-order-302148051.html